Lewis E. Fry
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Real-World Engagement with Free Genotyping by Patients with Inherited Retinal Disease in a Single Private Retinal Centre in Australia.
Journal: Seminars in ophthalmology
Published: June 30, 2025
Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration.
Journal: Communications biology
Published: April 02, 2024
The gut microbiome and primary open angle glaucoma: Evidence for a 'gut-glaucoma' axis?
Journal: European journal of ophthalmology
Published: December 12, 2023
RNA-targeting strategies as a platform for ocular gene therapy.
Journal: Progress in retinal and eye research
Published: April 25, 2022
Expression of Rab Prenylation Pathway Genes and Relation to Disease Progression in Choroideremia.
Journal: Translational vision science & technology
Published: July 13, 2021
CRISPR genome engineering for retinal diseases.
Journal: Progress in molecular biology and translational science
Published: June 27, 2021
Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
Journal: Expert opinion on orphan drugs
Published: May 27, 2021
Analysis of Pathogenic Variants Correctable With CRISPR Base Editing Among Patients With Recessive Inherited Retinal Degeneration.
Journal: JAMA ophthalmology
Published: January 28, 2021
Promoter Orientation within an AAV-CRISPR Vector Affects Cas9 Expression and Gene Editing Efficiency.
Journal: The CRISPR journal
Published: August 25, 2020
Last Updated: 09/26/2026